Erwin Blomsma
CEO and co-founder
Benno Therapeutics
Leuven, Belgium
My organisation
About me
Erwin Blomsma holds a Master’s degree in Bioscience Engineering and a Ph.D. in Applied Biological Sciences (1995) from KU Leuven in Belgium. After post-doctoral studies at UCB he started his career at Janssen Pharmaceutica in 1996. In 2000 he co-founded Crystallics, a spin-off from the University of Leiden (NL) specializing in preformulation research. Crystallics was absorbed by Avantium Technologies in 2001, and he was appointed Chief Operating Officer there in 2004.
In 2007, Dr Blomsma joined Dr Stefaan Wera and Professor Johan Neyts as co-founder and CEO of Okapi Sciences. He became Vice President of Aratana Therapeutics after the acquisition of Okapi Sciences by Aratana in 2014. In July 2015 he co-founded spinoff ViroVet. Erwin Blomsma is the active CEO of Benno Therapeutics, an animal health company focused on pet oncology, and COO and co-founder of NanoTherix, a one health company developing nanobody drug conjugates. Furthermore, Erwin Blomsma is board member of BioVia and CEO and co-founder and CEO of ViroVet.
Additional questions
Interests
What is your primary goal for attending this event?
Speaker sessions (1)
Thursday, 21 May 2026
11:00 - 12:00
Keynote: Trends and technologies transfer across species
This keynote delves into the translation of innovations from the human health (HH) sector into the animal health (AH) domain—whether through the adaptation of mature technologies or through concurrent development strategies.